CureVac Raises a Total of USD 640 Million in Private Financing Round
CureVac AG announced the closing of its latest private financing round, raising a total of USD 640 million (560 million Euros). The financing round included previously announced equity investments by the German government via the Kreditanstalt für Wiederaufbau (KfW) with USD 343 million and GSK with USD 171 million as well as additional new equity investments from Qatar Investment Authority (QIA) and a group of existing and new investors with approximately USD 126 million.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Revolutionary breakthrough: bacteria help in the circular economy of rare earths - Recycling Rare Earths with biomass: Previously uninvestigated strains of cyanobacteria can adsorb metals
Successful £2.4m funding round takes Lab901 Limited to the next level

Molecular factories: The combination between nature and chemistry is functional
Protagen Expands Cooperation with Bayer HealthCare

Blackbirds in the spotlight - City birds that experience light at night are ready to breed earlier than their rural cousins
Kansas State University professor's USDA research shows mad cow disease also caused by genetic mutation
